AVONHURST ADVISES LIMERSTON CAPITAL ON ITS ACQUISTION OF MEDICAL ENGINEERING TECHNOLOGIES

Avonhurst has advised Limerston Capital on its acquisition of Medical Engineering Technologies (MET). Corporate partner Emmanuel Amos led the Avonhurst team, supported by Joshua Swerner and Tom Mawson.

MET specialises in medical device and pharmaceutical testing and is based in Dover, UK with a substantial customer base of leading international innovators and manufacturers.

Emmanuel Amos, Corporate partner, comments:

“It was great to work again with Limerston Capital on their second acquisition under their Wickham Micro platform. MET is an exciting acquisition that will enhance Wickham Micro’s strong offering to medical device and pharma manufacturers.”